Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Oncology|May 24, 2012
Overexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy ResponseRita Spilka, Klaus Laimer, Felix Bachmann, et al.
Elife|January 29, 2020
High-speed motility originates from cooperatively pushing and pulling flagella bundles in bilophotrichous bacteriaKlaas Bente, Sarah Mohammadinejad, Mohammad Avalin Charsooghi, et al.
Molecular Cancer Therapeutics|August 20, 2016
The Novel Tubulin-Binding Checkpoint Activator BAL101553 Inhibits EB1-Dependent Migration and Invasion and Promotes Differentiation of Glioblastoma Stem-like CellsRaphaël Bergès, Aurélie Tchoghandjian, Stéphane Honoré, et al.
Environmental Science and Pollution Research International|February 28, 2023
Enzymatic post-treatment of ozonation: laccase-mediated removal of the by-products of acetaminophen ozonationDorothee Schmiemann, Lisa Hohenschon, Indra Bartels, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2017
The novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor modelsAshish Sharma, Angela Broggini-Tenzer, Van Vuong, et al.
Journal of Molecular Biology|February 18, 2014
The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organizationAndrea E Prota, Franck Danel, Felix Bachmann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 6, 2022
The effects of positive end-expiratory pressure on cardiac function: a comparative echocardiography-conductance catheter studyDavid Berger, Olivier Wigger, Stefano de Marchi, et al.
JCI Insight|August 17, 2021
Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin)Vassilis Genoud, Felipe I Espinoza, Eliana Marinari, et al.
International Journal of Cancer|October 25, 2002
DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancerGabriele Mild, Felix Bachmann, Jean-Louis Boulay, et al.
Pageof 3